Is There a Role for Systemic Corticosteroids in the Management of Stable Chronic Obstructive Pulmonary Disease?

2003 ◽  
Vol 2 (6) ◽  
pp. 451-458 ◽  
Author(s):  
Richard Wood-Baker
2010 ◽  
Vol 181 (2) ◽  
pp. 150-157 ◽  
Author(s):  
Johannes M. A. Daniels ◽  
Dominic Snijders ◽  
Casper S. de Graaff ◽  
Fer Vlaspolder ◽  
Henk M. Jansen ◽  
...  

2017 ◽  
Vol 217 (9) ◽  
pp. 504-509
Author(s):  
J.A. Rueda-Camino ◽  
D. Bernal-Bello ◽  
J. Canora-Lebrato ◽  
L. Velázquez-Ríos ◽  
V. García de Viedma-García ◽  
...  

2017 ◽  
Vol 11 (2) ◽  
Author(s):  
Domenico Lorenzo Urso

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. Acute exacerbations of COPD (AECOPD) are important events in the natural history of this condition because they negatively impact health status, rate of hospitalization, disease progression, and mortality.Viral and/or bacterial infections are the main cause of exacerbations. The treatments include systemic corticosteroids, bronchodilators, anticholinergics and/or short- or long-acting β2-agonists, and antibiotics in case of bacterial infections. In some cases, oxygen-therapy is indicated.This article focuses on several aspects of AECOPD, including epidemiology, diagnostic approach, i.e. investigations and management of AECOPD.


Sign in / Sign up

Export Citation Format

Share Document